HOXA9 promotes hematopoietic commitment of human embryonic stem cells

Area of Science:

• Stem Cell Biology
• Hematopoiesis
• Molecular Determinants of Cell Fate

Background:

• Hematopoietic differentiation of human embryonic stem cells (hESCs) is complex and not fully understood.
• HOXA9 is a key gene in hematopoiesis and leukemogenesis, with its expression levels critical for hematopoietic stem and progenitor cells (HSPCs).
• HOXA9 is significantly downregulated in hESC-derived HSPCs compared to cord blood HSPCs.

Purpose of the Study:

• To investigate the role of HOXA9 in the hematopoietic differentiation of hESCs.
• To determine how HOXA9 expression levels influence the commitment of hemogenic precursors (HEPs) to blood cells.
• To explore potential collaborating factors with HOXA9 in hESC-based hematopoiesis.

Main Methods:

• Analysis of gene expression differences between cord blood HSPCs and hESC-derived HSPCs.
• Gain-of-function and loss-of-function studies of HOXA9 during hESC hematopoietic differentiation.
• Flow cytometry to identify and quantify specific cell populations (e.g., CD31, CD34, CD45).
• Gene expression analysis to explore signaling pathways involved.

Main Results:

• HOXA9 expression in differentiating hESCs is restricted to hemogenic precursors (CD31(+)CD34(+)CD45(-)) and decreases upon differentiation into CD45(+) blood cells.
• HOXA9 overexpression enhances the commitment of HEPs to primitive and total CD45(+) blood cells.
• Nuclear factor-κB signaling may cooperate with HOXA9 in promoting hematopoietic commitment.

Conclusions:

• HOXA9 plays a critical role in promoting hematopoietic differentiation from hESCs by regulating HEP commitment.
• HOXA9 alone is insufficient to confer long-term in vivo engraftment potential, indicating the need for additional regulators for definitive HSPC generation.
• Understanding HOXA9's function provides insights into generating functional hematopoietic cells from stem cells.